HealthEquity (HQY) insider plans 1,087-share stock sale after restricted vesting
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
HealthEquity, Inc. insider Delano Ladd filed a notice of intent to sell common stock. The planned sale covers 1,087 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $103,355.31, targeted for July 8, 2026 on NASDAQ. These shares relate to restricted stock vesting events dated March 29, 2023, March 27, 2024, and April 2, 2025, totaling 354, 345, and 388 shares, respectively. The filing also lists a prior Rule 10b5-1 sale of 7,500 shares of common stock for $649,200.00 on May 28, 2026.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 1,087 shares
Aggregate market value of planned sale: $103,355.31
10b5-1 shares sold: 7,500 shares
+4 more
7 metrics
Planned shares to be sold
1,087 shares
Common stock planned for sale on or after July 8, 2026
Aggregate market value of planned sale
$103,355.31
Total market value for 1,087 shares of common stock
10b5-1 shares sold
7,500 shares
Common stock sold on May 28, 2026 under a 10b5-1 plan
Proceeds from 10b5-1 sale
$649,200.00
Total consideration for 7,500 shares sold on May 28, 2026
Restricted stock vesting 2023
354 shares
Compensation common stock vesting on March 29, 2023
Restricted stock vesting 2024
345 shares
Compensation common stock vesting on March 27, 2024
Restricted stock vesting 2025
388 shares
Compensation common stock vesting on April 2, 2025
Key Terms
Form 144, Restricted Stock Vesting, 10b5-1, Aggregate market value
4 terms
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Vesting financial
"Common Stock | 04/02/2025 | Restricted Stock Vesting | ISSUER"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
10b5-1 regulatory
"10b5-1 Sales for Delano Ladd C/O HealthEquity, Inc."
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Aggregate market value financial
"Common Stock | Morgan Stanley Smith Barney ... | 1087 | 103355.31"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.